The Longevity of Sirtuins

by David Sinclair, Eric Verdin
Published 2012-12-01

Clinical Evidence for Targeting NAD Therapeutically

by Dina Radenkovic, Reason, Eric Verdin
Published 2020-09-01

Inhibition of SIRT2 Potentiates the Anti-motility Activity of Taxanes: Implications for Antineoplastic Combination Therapies

by Katiuscia Bonezzi, Dorina Belotti, Brian J. North, Carmen Ghilardi, Patrizia Borsotti, Andrea Resovi, Paolo Ubezio, Antonella Riva, Raffaella Giavazzi, Eric Verdin, Giulia Taraboletti
Published 2012-09-01

Sialyl-LewisX Glycoantigen Is Enriched on Cells with Persistent HIV Transcription during Therapy

by Florent Colomb, Leila B. Giron, Leticia Kuri-Cervantes, Opeyemi S. Adeniji, Tongcui Ma, Harsh Dweep, Emilie Battivelli, Eric Verdin, Clovis S. Palmer, Hiroaki Tateno, Andrew V. Kossenkov, Nadia R. Roan, Michael R. Betts, Mohamed Abdel-Mohsen
Published 2020-08-01

An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients.

by Celsa A Spina, Jenny Anderson, Nancie M Archin, Alberto Bosque, Jonathan Chan, Marylinda Famiglietti, Warner C Greene, Angela Kashuba, Sharon R Lewin, David M Margolis, Matthew Mau, Debbie Ruelas, Suha Saleh, Kotaro Shirakawa, Robert F Siliciano, Akul Singhania, Paula C Soto, Valeri H Terry, Eric Verdin, Christopher Woelk, Stacey Wooden, Sifei Xing, Vicente Planelles
Published 2013-01-01